2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33796409 | Tumor regression and immunity in combination therapy with anti-CEA chimeric antigen receptor T cells and anti-CEA-IL2 immunocytokine. | 2021 Mar 18 | 2 |
2 | 27605551 | Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells. | 2016 Sep 7 | 4 |